ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 66 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $454,000 | -11.7% | 14,750 | -15.7% | 0.15% | +98.6% |
| Q1 2016 | $514,000 | -90.6% | 17,487 | -85.6% | 0.07% | -86.1% |
| Q2 2015 | $5,448,000 | +723.0% | 121,085 | +460.2% | 0.53% | +718.5% |
| Q1 2015 | $662,000 | -39.8% | 21,615 | -0.0% | 0.06% | -38.1% |
| Q4 2014 | $1,099,000 | -70.4% | 21,618 | -76.9% | 0.10% | -67.3% |
| Q3 2014 | $3,711,000 | +703.2% | 93,771 | +364.9% | 0.32% | +1428.6% |
| Q3 2013 | $462,000 | +17.9% | 20,168 | -8.9% | 0.02% | +31.2% |
| Q2 2013 | $392,000 | – | 22,149 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |